Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.75B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 3 |
Procter & Gamble
PG
|
+$980M |
| 4 |
Apple
AAPL
|
+$894M |
| 5 |
Amazon
AMZN
|
+$815M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$806M |
| 2 |
Palo Alto Networks
PANW
|
+$726M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$654M |
| 4 |
Toronto Dominion Bank
TD
|
+$494M |
| 5 |
Enbridge
ENB
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.1% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.8% |
| 4 | Healthcare | 7.3% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6126
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
$4.19B
| $26K | ﹤0.01% |
+765
| New | +$24.2K |
|
|
MVO
6127
DELISTED
MV Oil Trust
MVO
| $26K | ﹤0.01% |
2,150
+1,450
| +207% | +$17.7K |
|
6128
Opus Small Cap Value ETF
OSCV
$715M
| $26K | ﹤0.01% |
787
-54,099
| -99% | -$1.69M |
|
6129
Praxis Precision Medicines
PRAX
$10.2B
| $26K | ﹤0.01% |
+1,157
| New | +$20.8K |
|
6130
SoFi Select 500 ETF
SFY
$704M
| $26K | ﹤0.01% |
302
-1,796
| -86% | -$143K |
|
6131
Travelzoo
TZOO
$73.4M
| $26K | ﹤0.01% |
2,767
+1,355
| +96% | +$10.8K |
|
6132
Workhorse Group
WKHS
$33.3M
| $26K | ﹤0.01% |
24
+14
| +140% | +$16.7K |
|
|
MAGN
6133
Magnera Corp
MAGN
$444M
| $26K | ﹤0.01% |
1,054
+482
| +84% | +$10.1K |
|
|
ACLC
6134
American Century Large Cap Equity ETF
ACLC
$323M
| $26K | ﹤0.01% |
438
-8,378
| -95% | -$465K |
|
|
SPRB
6135
Spruce Biosciences
SPRB
$151M
| $26K | ﹤0.01% |
119
-10
| -8% | -$1.16K |
|
|
DZSI
6136
DELISTED
DZS Inc. Common Stock
DZSI
| $26K | ﹤0.01% |
13,457
+9,795
| +267% | +$15.3K |
|
6137
Aclaris Therapeutics
ACRS
$851M
| $25K | ﹤0.01% |
23,388
+10,083
| +76% | +$30.8K |
|
6138
Forafric Global
AFRI
$286M
| $25K | ﹤0.01% |
2,366
+1,116
| +89% | +$12.3K |
|
6139
FlexShares Core Select Bond Fund
BNDC
$170M
| $25K | ﹤0.01% |
1,134
| – | – |
|
6140
Babcock & Wilcox
BW
$1.53B
| $25K | ﹤0.01% |
17,642
+7,999
| +83% | +$17K |
|
|
CARM
6141
DELISTED
Carisma Therapeutics
CARM
| $25K | ﹤0.01% |
8,491
+4,014
| +90% | +$11.9K |
|
6142
dLocal
DLO
$4.17B
| $25K | ﹤0.01% |
1,377
-38
| -3% | -$680 |
|
|
HYPD
6143
Hyperion DeFi Inc
HYPD
$41.2M
| $25K | ﹤0.01% |
154
-180
| -54% | -$21.2K |
|
|
GNT
6144
GAMCO Natural Resources, Gold & Income Trust
GNT
$147M
| $25K | ﹤0.01% |
4,960
| – | – |
|
6145
CALL
Ionis Pharmaceuticals
IONS
$9.51B
| $25K | ﹤0.01% |
500
| – | – |
|
6146
Century Therapeutics
IPSC
$348M
| $25K | ﹤0.01% |
7,447
+3,151
| +73% | +$5.74K |
|
6147
NET Power
NPWR
$172M
| $25K | ﹤0.01% |
2,482
-1,157
| -32% | -$13.9K |
|
6148
PLDT
PHI
$4.17B
| $25K | ﹤0.01% |
1,082
-28
| -3% | -$627 |
|
6149
Weibo
WB
$1.88B
| $25K | ﹤0.01% |
2,242
-4,340
| -66% | -$49.3K |
|
|
GAU
6150
Galiano Gold
GAU
$547M
| $24K | ﹤0.01% |
25,692
-3,216
| -11% | -$2K |
|
Similar funds
Royal Bank of Canada's Q4 2023 Portfolio in Review
As of Q4 2023, Royal Bank of Canada held 7,942 positions worth $428B, up 16% from $369B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $17.2B of net new capital in Q4 2023, opening 466 new positions and adding to 4,113 existing holdings. Its largest new stake was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was PepsiCo, an estimated $806M trimmed.
- Royal Bank of Canada's largest Q4 2023 buy was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $8.75B increase.
- Royal Bank of Canada's biggest Q4 2023 reduction was PepsiCo, cutting an estimated $806M.
- Royal Bank of Canada fully exited Activision Blizzard in Q4 2023, selling an estimated $69.3M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $428B portfolio in Q4 2023.
- Royal Bank of Canada opened 466 new positions and closed 401 in Q4 2023.
- Royal Bank of Canada's portfolio value rose 16% quarter-over-quarter to $428B.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.